Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the literature, in some selected cases, peptide receptor...
Guardado en:
Autores principales: | Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, Alicja Hubalewska-Dydejczyk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1254a0f6a8cc42f8becf30fad0bed1c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
por: Marta Opalińska, et al.
Publicado: (2021) -
A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor
por: Kentaro Miura, et al.
Publicado: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021) -
Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
por: Marianne S. Elston, et al.
Publicado: (2021) -
Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems
por: Modesto J Varas Lorenzo, et al.
Publicado: (2019)